Lung Cancer Panel 7 EGFR BRAF ALK1 ROS1 MET
Introduction to the Test
The Lung Cancer Panel 7 EGFR BRAF ALK1 ROS1 MET is an advanced genetic test that plays a pivotal role in the diagnosis and management of lung cancer. This test is essential for identifying specific mutations that can influence treatment options and prognosis, allowing for a tailored approach to patient care.
What the Test Measures
This panel detects mutations in key genes associated with lung cancer, including:
- EGFR (Epidermal Growth Factor Receptor)
- BRAF (B-Raf Proto-Oncogene)
- ALK1 (Anaplastic Lymphoma Kinase)
- ROS1 (ROS Proto-Oncogene 1)
- MET (Mesenchymal-Epithelial Transition Factor)
By identifying these mutations, healthcare providers can better understand the tumor’s behavior and select the most effective treatments.
Who Should Consider This Test?
This test is recommended for patients who:
- Are diagnosed with non-small cell lung cancer (NSCLC)
- Have a family history of lung cancer
- Exhibit symptoms such as persistent cough, chest pain, or unexplained weight loss
- Are considering targeted therapy options
Benefits of Taking the Test
- Enables personalized treatment plans based on genetic mutations.
- Helps in early detection and better management of lung cancer.
- Increases the likelihood of successful treatment outcomes.
- Provides valuable information for clinical decision-making.
Understanding Your Results
The results of the Lung Cancer Panel 7 will indicate the presence or absence of genetic mutations. A positive result could mean that targeted therapies may be effective, while a negative result may suggest alternative treatment options. It is crucial to discuss the results with your healthcare provider to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 720,000 |
| Regular Price | 960,000 |
Book the Test
To book the Lung Cancer Panel 7 EGFR BRAF ALK1 ROS1 MET test, please call or WhatsApp us at +2348077798758. Early detection can make a significant difference in your treatment journey. Don’t wait – take control of your health today!
Pre-Test Instructions
The Lung Cancer Panel 7 can be performed with a Doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Turnaround Time
The results will be available within 5-7 days after sample collection.
Sample Type
This test requires tumor tissue, specifically paraffin-embedded tissue blocks.
Testing Methodology
The test employs advanced methodologies, including FISH (Fluorescence In Situ Hybridization) and Sanger Sequencing, to ensure accurate and reliable results.
